Walk down the vitamins and supplements aisle of a pharmacy or grocery store, and you’ll see a mind-boggling array of options. It can be hard to know which one is best. And if you’re a cancer patient looking for the right dietary supplement, there are even more issues to take into account. How do you … Read more
At this year’s American Society of Hematology Annual Meeting, Dana-Farber scientists presented major findings that could one day improve diagnosis and treatment of blood cancers, extend life, or even cure some diseases. Among the highlights: Steven Treon, MD, PhD, and his colleagues identified a gene mutation that underlies the vast majority of cases of Waldenström’s … Read more
Harold J. Burstein, MD, PhD, a Dana-Farber breast cancer specialist, discusses some of the important studies presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. The five-day meeting includes more than 1,000 scientific presentations, seminars, and posters, with a focus on emerging treatments in hard-to-treat populations, patients with metastatic breast cancer, and breast cancer … Read more
Ann Partridge, MD, MPH, was instrumental in the founding of Dana-Farber’s Program for Young Women with Breast Cancer, part of the Susan F. Smith Center for Women’s Cancers. The program, which focuses on the unique needs of breast cancer patients under 40, helps patients access fertility, genetic screening, and counseling services. Dr. Partridge was recently … Read more
Siddhartha Mukherjee, MD, PhD, was a postdoctoral fellow at Dana-Farber in 2003 when one of his patients asked him, “What is it, exactly, that I am battling?” Mukherjee took this simple, yet profound, question seriously. The answer formed the basis for his 2011 Pulitzer Prize-winning book, The Emperor of All Maladies: A Biography of Cancer. … Read more